Healthcare Industry News: Miramar Labs
News Release - October 7, 2014
Miramar Labs Expands Management TeamMiramar Labs Appoints Rob Ellis as VP of Marketing
SANTA CLARA, Calif., Oct. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Miramar Labs® Inc., a leading medical device manufacturer and maker of the miraDry® System, today announced the expansion of its management team.
Rob Ellis joins Miramar Labs as Vice President of Marketing. With over 22 years of sales and marketing experience and the last 12 of those working with Aesthetic Medical Device organizations, Mr. Ellis brings an in-depth understanding of the aesthetic market and the key physician relationships to expand the miraDry business globally. Just prior to joining Miramar Labs, Mr. Ellis ran his own consulting firm where he worked with startups to raise funds and establish initial sales and marketing teams. Previously, Mr. Ellis held senior management positions such as VP of Global Marketing for Lumenis and Director of Marketing for Sciton.
Miramar Labs also announced the recent appointments of Will Johnson as Senior Director of North American Sales, Carter Morgan as Senior Director of Sales for Latin America & Europe and Robert Tyson as Sales Director for the Eastern Region.
In addition to his many years' experience in the aesthetic device industry, Mr. Johnson was formerly the Director of the Central Region for Miramar Labs, was one of the first sales representatives for Miramar Labs and led the successful sales launch of the miraDry system.
Mr. Morgan joined Miramar Labs in July 2013 to head up the west sales region in the US and his responsibilities were quickly expanded to cover Latin America and Europe as well. Mr. Morgan has extensive experience in medical devices with key positions such as Vice President of Latin America for Syneron and Vice President of Worldwide Sales for Sound Surgical Technologies.
Mr. Tyson joins Miramar with several years' experience in the aesthetic medical device arena having most recently been the VP of North American Sales for Zeltiq. Mr. Tyson also held previous sales management positions with Ulthera, Reliant Technologies and Thermage.
"I am excited about the future of miraDry in the U.S. and abroad. I believe with the aesthetic experience this seasoned leadership team brings to Miramar, we will quickly and efficiently grow both new system sales and procedure volume throughout North America" stated Mike Kleine, CEO of Miramar Labs. "And though I am enthusiastic with the great success outside North America, specifically in our Asian Pacific markets with the promotion of underarm odor reduction, I am equally excited about our potential to quickly and substantially increase our North American markets through expanded indications and new treatments".
The miraDry System delivers energy non-invasively to the area under the arm where sweat glands reside, creating localized heat to destroy and eliminate those glands. Since sweat glands do not regenerate, results are lasting. The treatment is very effective and provides high patient satisfaction. On average, patients see more than 80 percent reduction in underarm sweat and report more than 90 percent satisfaction with the procedure results.
For more information, visit the miraDry website at www.miraDry.com, or follow miraDry on Facebook/miraDry and Twitter @miraDry.
About Miramar Labs
Founded in 2006, Miramar Labs is a privately owned medical device company offering the only FDA approved device for the permanent reduction of underarm sweat and odor. Miramar Labs is the tenth company created by The Foundry, a leading medical device incubator based in Menlo Park, California. Supported by rigorous clinical research, Miramar Labs is focused on addressing medical conditions for which there are significant unmet clinical needs. Physicians and patients are encouraged to visit www.miradry.com for additional information about Miramar Labs.
Source: Miramar Labs
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.